Anti-osteoporosis Medication Monitoring and Management Service
Status
Conditions
Details and patient eligibility
About
BACKGROUND:
One-year adherence to oral anti-osteoporosis medication (AOMs) was only about 30%. In recent years, efforts have been made to change the delivery of these medications from oral form to injection form every, 3, 6 or 12 months to increase adherence. However, both patients and providers are sometimes confused about the multiple choices. Also, patients may receive extra medications if providers did not keep tract of their previous AOM uses or patients may changes providers. There were urgent needs to provide AOM monitoring and management services to improve cares.
OBJECTIVES:
To establish a anti-osteoporosis medication management service at National Taiwan University Hospital and its BeiHu Branch.
METHODS:
Participating physicians will select those eligible for services and refer to study coordinators. Study coordinators will conduct baseline assessments on osteoporosis/fracture risks, record medical conditions, AOMs, provide educations on osteoporosis, fracture, sarcopenia, fall, medications, nutrition, and exercise. They also arrange return clinic visit, telephone reminder and follow up for patients, and communicate with providers on regular bases. the investigators plan to enroll 500 patients with 18-month follow up for each.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Age >=50 and one of the below
- Newly prescribed with AOMs
- Recent change of AOMs
- Poor adherence to AOMs
- Participating physicians feel that the service will benefit the patient in overall osteoporosis and medication managements.
Exclusion criteria
- Life expectancy less than 2 years or can't be assessed for communication problems
- patient in our fracture liaison service or other medication clinical trials
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal